If you have any questions or would like to learn more about how medical advancements can support your health journey, Schedule a consultation with us today!
Harijan RK, Hoff O, Ducati RG, Firestone RS, Hirsch BM, Evans GB, Schramm VL, Tyler PC (2019) Selective inhibitors of Helicobacter pylori methylthioadenosine nucleosidase and human methylthioadenosine phosphorylase
D.WhartonS.et al
Finally, when compared with placebo, SGLT-2 inhibitors are associated with a robust reduction of hospitalization for HHF and renal outcome, and a moderate reduction of CV and total death, and MACE [13]
10.1016/j.jafr.2025.101630 67 MuhlbergE.BurtscherM.UmstatterF.FrickerG.MierW.UhlP
Due to the low incidence of various thyroid disorders, these findings still need to be verified by further studies